AMNOL

Novara, Italy Founded: 1978 • Age: 48 yrs Acquired By Ceres Pharma
Dermo-cosmetics products are manufactured by AMNOL in Italy.

About AMNOL

AMNOL is a Healthcare company based in Novara (Italy) founded in 1978, and was acquired by Ceres Pharma in May 2023. Dermo-cosmetics products are manufactured by AMNOL in Italy. Its chief executive, as recorded, is Giorgio Stefanelli. Its focus areas include Cosmeceuticals. Its legal entity is Ceres Pharma Italy S.r.l.

Company details

AMNOL was established in 1978 in Novara, Italy, where operations focus on the production of dermo-cosmetics. The company specializes in this sector, developing and manufacturing skincare and cosmetic items tailored for dermatological needs. Leadership is provided by CEO Giorgio Stefanelli. Activities are centered in Italy, serving markets through its domain amnol.net, with an emphasis on quality-controlled formulations.

  • Headquarters Novara, Italy
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website amnol.net
  • Social LinkedIn Facebook Instagram
  • Acquired by Ceres Pharma (May 2023)
  • Legal Name Ceres Pharma Italy S.R.L
Key Metrics

Investors in AMNOL

AMNOL has secured backing from 1 investor. Prominent investors backing the company include Ceres Pharma.

All
InvestorDescriptionFounded YearDomainLocation
Nutritional supplements are manufactured and marketed by Ceres Pharma.
2017ceres-pharma.comMerelbeke, Belgium
Premium access

Investor details for AMNOL

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of AMNOL

1 people are tracked at AMNOL (1 in leadership).

NameRoleGroup
Giorgio Stefanelli
CEOLeadership
Premium access

Complete people profiles for AMNOL

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of AMNOL

2 dated milestones of AMNOL across 45 years, from founding to its latest funding, stage changes and deals.

  1. Founded AMNOL is founded.
  2. Exit Acquired by Ceres Pharma.

Web traffic of AMNOL

The website of AMNOL (amnol.net) receives about 1.4K visits a month.

  • Monthly visits
    1.4K

    ▼ 29.7% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about AMNOL

AMNOL was founded in 1978.

AMNOL is headquartered in Novara, Italy. It is registered at Novara, Piedmont, Italy.

Giorgio Stefanelli is the CEO of AMNOL, as recorded in our data.

AMNOL was established in 1978 in Novara, Italy, where operations focus on the production of dermo-cosmetics. The company specializes in this sector, developing and manufacturing skincare and cosmetic items tailored for dermatological needs. Leadership is provided by CEO Giorgio Stefanelli. Activities are centered in Italy, serving markets through its domain amnol.net, with an emphasis on quality-controlled formulations.

AMNOL has 1 investor. Key investors include Ceres Pharma.

AMNOL operates through Ceres Pharma Italy S.R.L.

Yes. AMNOL was acquired by Ceres Pharma in May 2023.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available